Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug Conjugate

Published 2018 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug Conjugate
Authors
Keywords
-
Journal
MOLECULAR CANCER THERAPEUTICS
Volume 17, Issue 4, Pages 795-805
Publisher
American Association for Cancer Research (AACR)
Online
2018-02-27
DOI
10.1158/1535-7163.mct-17-0710

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.